Prescient Therapeutics Limited (ASX:PTX)

Ligand Pharmaceuticals Statistics

Total Valuation

ASX:PTX has a market cap or net worth of AUD 45.09 million. The enterprise value is 36.72 million.

Market Cap	45.09M
Enterprise Value	36.72M

Important Dates

The next estimated earnings date is Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:PTX has 980.32 million shares outstanding. The number of shares has increased by 2.11% in one year.

Current Share Class	980.32M
Shares Outstanding	980.32M
Shares Change (YoY)	+2.11%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	10.32%
Owned by Institutions (%)	0.43%
Float	865.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.93
PB Ratio	2.88
P/TBV Ratio	3.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.20
EV / Sales	12.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.97, with a Debt / Equity ratio of 0.00.

Current Ratio	15.97
Quick Ratio	14.54
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-617.21

Financial Efficiency

Return on equity (ROE) is -36.95% and return on invested capital (ROIC) is -18.98%.

Return on Equity (ROE)	-36.95%
Return on Assets (ROA)	-17.58%
Return on Invested Capital (ROIC)	-18.98%
Return on Capital Employed (ROCE)	-37.16%
Revenue Per Employee	1.01M
Profits Per Employee	-2.36M
Employee Count	3
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.20% in the last 52 weeks. The beta is 0.51, so ASX:PTX's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	+12.20%
50-Day Moving Average	0.05
200-Day Moving Average	0.05
Relative Strength Index (RSI)	52.20
Average Volume (20 Days)	1,466,843

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:PTX had revenue of AUD 3.02 million and -7.07 million in losses. Loss per share was -0.01.

Revenue	3.02M
Gross Profit	3.02M
Operating Income	-5.81M
Pretax Income	-7.07M
Net Income	-7.07M
EBITDA	-5.81M
EBIT	-5.81M
Loss Per Share	-0.01

Balance Sheet

The company has 8.41 million in cash and 34,275 in debt, giving a net cash position of 8.37 million or 0.01 per share.

Cash & Cash Equivalents	8.41M
Total Debt	34,275
Net Cash	8.37M
Net Cash Per Share	0.01
Equity (Book Value)	15.65M
Book Value Per Share	0.02
Working Capital	13.99M

Cash Flow

Operating Cash Flow	-9.70M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -192.44% and -233.95%.

Gross Margin	100.00%
Operating Margin	-192.44%
Pretax Margin	-233.95%
Profit Margin	-233.95%
EBITDA Margin	-192.43%
EBIT Margin	-192.44%
FCF Margin	n/a

Dividends & Yields

ASX:PTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.11%
Shareholder Yield	n/a
Earnings Yield	-15.67%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 2, 2014. It was a reverse split with a ratio of 0.05.

Last Split Date	Dec 2, 2014
Split Type	Reverse
Split Ratio	0.05

Scores

ASX:PTX has an Altman Z-Score of 17.5 and a Piotroski F-Score of 2.

Altman Z-Score	17.5
Piotroski F-Score	2